In a report released today, Stephen Grambling from Morgan Stanley maintained a Buy rating on Viking Holdings Ltd (VIK – Research Report), with ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating for Viking Holdings, raising the price target to $58 from $50.

The Minnesota Vikings are primed to franchise tag QB Sam Darnold and then trade him in an unprecedented NFL move.

That was before quarterback guru Kevin O'Connell arrived in Minnesota. He's made the Vikings a dream destination for any ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...

The Minnesota Vikings have a good problem on their hands. In a league where solid quarterback play is tough to find, the ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $34.94 which represents a slight increase of $0.89 or 2.61% from the prior close of $34.05. The stock opened at $33.85 and ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Viking’s focus on educational experiences ... market share within the expanding global vacation market. Price Action: VIK shares are trading higher by 5.79% at $47.75 on the last check Friday.